|
Market Closed -
Nasdaq
02:30:00 14/11/2026 am IST
|
5-day change | 1st Jan Change | ||
| 28.83 USD | +1.05% |
|
-3.48% | +6.15% |
| 06/11 | Celldex Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026 | CI |
| 23/09 | Top Midday Decliners | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +1.05% | -3.48% | +3.57% | -31.28% | +6.15% | +12.84% | +3.33% | -31.31% | -60.93% | 226.45Cr | |
| -2.69% | -0.48% | -5.11% | -8.13% | +61.41% | +53.97% | +70.99% | +13.50% | - | 6.63TCr | |
| -0.92% | +7.67% | +17.72% | +20.30% | +22.54% | +12.64% | +92.55% | +224.85% | +6,178.77% | 6.06TCr | |
| 0.00% | +0.39% | +13.77% | +18.38% | +23.84% | +22.34% | +90.83% | -9.63% | +276.70% | 5.55TCr | |
| +0.14% | +2.35% | +18.51% | +19.87% | +37.11% | +13.86% | +106.64% | +10.00% | +1,088.42% | 4.76TCr | |
| -2.21% | -2.47% | +1.19% | +12.03% | +17.62% | +20.18% | +32.24% | +4.10% | +244.80% | 4.37TCr | |
| -2.30% | -10.40% | -10.97% | -15.42% | +116.31% | +154.30% | +725.54% | +424.79% | - | 3.73TCr | |
| +2.15% | +1.42% | +19.02% | +6.47% | +24.14% | +14.58% | +54.23% | +21.92% | +193.10% | 3.66TCr | |
| -2.32% | -2.24% | +38.98% | +70.10% | +70.10% | +76.50% | +54.55% | +22.18% | +186.86% | 3.22TCr | |
| +2.62% | +5.90% | +23.90% | -2.09% | -30.38% | -37.29% | +393.72% | +280.29% | +701.85% | 2.66TCr | |
| -4.38% | -1.85% | -6.03% | +3.54% | +48.66% | +40.28% | -2.22% | -55.49% | - | 2.44TCr | |
| +0.66% | -2.18% | -3.45% | -8.05% | -10.08% | -16.97% | -14.96% | -64.05% | - | 2.12TCr | |
| -0.44% | +0.13% | +6.05% | +13.04% | +16.43% | +10.82% | +131.76% | +194.74% | +1,785.10% | 1.83TCr | |
| +3.12% | +7.23% | +21.32% | +10.82% | - | - | - | - | - | 1.81TCr | |
| +1.10% | +8.66% | +15.97% | -8.00% | +225.70% | +218.59% | +393.11% | +1,472.94% | +873.51% | 1.74TCr | |
| -1.20% | -0.82% | +13.13% | +34.66% | +57.43% | +65.67% | +222.88% | +281.22% | +311.69% | 1.68TCr | |
| +0.02% | -0.74% | +13.00% | +24.90% | +40.99% | +49.22% | +69.00% | -16.98% | +119.95% | 1.66TCr | |
| -0.83% | +0.13% | +11.91% | +20.68% | +69.43% | +101.40% | +89.48% | -12.42% | +350.27% | 1.62TCr | |
| -2.92% | -4.93% | +15.20% | +19.31% | +6.82% | +20.02% | -27.08% | -31.83% | +140.81% | 1.46TCr | |
| -2.18% | -1.50% | +2.47% | -13.93% | +14.23% | -3.66% | +417.92% | - | - | 1.36TCr | |
| Average | -0.58% | -0.34% | +10.51% | +9.36% | +43.08% | +43.65% | +152.87% | +151.60% | +885.06% | 3TCr | |
| Weighted average by Cap. | -0.79% | +0.02% | +10.33% | +11.28% | +42.70% | +41.11% | +147.27% | +125.60% | +1,350.47% |
- Stock Market
- Stocks
- CLDX Stock
- Sector Celldex Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
